BlackRock Health Sciences Term Trust (NYSE:BMEZ) Director Robert Fairbairn Sells 10,294 Shares of Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) Director Robert Fairbairn sold 10,294 shares of the stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

BlackRock Health Sciences Term Trust Stock Down 0.1%

Shares of BMEZ stock opened at $15.17 on Tuesday. BlackRock Health Sciences Term Trust has a 52 week low of $12.58 and a 52 week high of $16.75. The company has a 50-day simple moving average of $15.05 and a 200 day simple moving average of $14.57.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, December 31st. Stockholders of record on Monday, December 22nd will be issued a dividend of $0.11 per share. This represents a c) dividend on an annualized basis and a dividend yield of 8.7%. The ex-dividend date is Monday, December 22nd.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in BMEZ. PMG Family Office LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the third quarter valued at about $411,000. Allworth Financial LP raised its stake in BlackRock Health Sciences Term Trust by 24,584.6% in the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after purchasing an additional 3,196 shares in the last quarter. NewEdge Advisors LLC boosted its holdings in BlackRock Health Sciences Term Trust by 17.9% in the 3rd quarter. NewEdge Advisors LLC now owns 56,941 shares of the company’s stock valued at $821,000 after purchasing an additional 8,641 shares during the period. Susquehanna International Group LLP acquired a new position in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $1,097,000. Finally, City of London Investment Management Co. Ltd. bought a new position in shares of BlackRock Health Sciences Term Trust during the third quarter worth approximately $1,068,000.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.